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Introduction
 Cancer is one of the leading causes of death in the 
world. It was estimated that 12 million new cases of cancer 
were occurred all over the world. Cancers accounted for 
7.6 million deaths (13% of all deaths) in 2008. According 
to Globocan 2008, the age-standardized incidence rates 
(ASR) of all cancers were 202.8 and 164.4 per 100000 
person-year among male and female, respectively. 
Leukemias were reported as one of the 9th and 10th common 
cancers in men and women, respectively (Ferlay et al., 
2010). 
 Leukemias are a hetrogenous group of hematopoietic 
malignancies that included four major subtypes of 
leukemias described by most cancer registries include 
Acute Lymphoblastic Leukemia (ALL), Acute Myeloid 
Leukemia (AML), Chronic Lymphoblastic Leukemia 
(CLL), and Chronic Myeloid Leukemia (CML) (Xie et 
al., 2003). Multiple Myeloma (MM) is a malignancy 
of B-cells that is characterized by aberrant expansion 
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and accumulation of malignant plasma cells in the bone 
marrow (Laubach et al., 2009).
 As stated in Globocan 2008, the ASRs of leukemia 
in men and women were 5.8 and 4.3 per 100000 person- 
year, respectively, all over the world. In more developed 
countries the rates were 9.1 and 5.9 per 100000 person-
year for male and female, respectively. These rates in less 
developed regions were 4.0 and 3.3 per 100000 person- 
year in men and women, respectively. In Iran, the ASRs 
of leukemia were 7.7 and 4.0 per 100000 person-year 
among male and female, respectively. Epidemiology of 
MM is similar to the leukemias. The ASRs of MM are 
higher in developed countries (male=3.3, female=2.2 
per 100000 person-year) than less developed areas 
(male= 0.7, female=0.8 per 100000 person- year). Risk 
factors for leukemia are previous chemotherapy, genetic 
disorders caused by abnormal chromosomes, human T cell 
leukemia virus, myelodysplastic syndrome (Rhomberg et 
al., 2011). Age and race are considered as risk factors for 
multiple myeloma. Exposure to radiation and occupational 
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exposures to high levels of benzene or formaldehyde are 
considered as risk factors for both multiple myeloma 
and leukemia (Romanenko et al., 2008; Yiin et al., 2009; 
Rhomberg et al., 2011).
 Monitoring the trend in cancer incidence is one of the 
most important functions of cancer surveillance system. 
Changes in the incidence of cancer in population can 
provide important information regarding potential changes 
in risk factors. It can help us approach more strategic 
to control cancers. Golestan Population-based Cancer 
Registry (GPCR) was established to achieve this goal in a 
high risk area for upper gastrointestinal cancers, so called 
as Golestan province of Iran. GPCR has been approved 
as a voting member of the International Association 
of Cancer Registries (IACR) and is now going on as a 
qualified cancer registry (Roshandel et al., 2012). The aim 
of this paper is to present the incidence rates of leukemia 
and multiple myeloma in GPCR during 2004-2009. 
 
Materials and Methods
 This was a descriptive cross-sectional study. GPCR 
registered only primary cancers while additional tumors 
that result from the invasion or metastasis of cancers to 
other organs were not considered. Malignant tumors of 
all organs were registered based on the IACR standards. 
Data on newly diagnosed (incident) leukemia and MM 
cases were collected from all public and private diagnostic 
and therapeutic centers (hospitals, pathology/laboratory 
centers, imaging centers and some of the specialist 
physician’s private offices) of the whole province. GPCR 
also had close collaboration with some of medical centers 
and regional registries outside the province to minimize 
loss of the data and consequent underestimation. Incidence 
data discussed in this paper are based on cases of primary 
cancers which were first diagnosed among Golestan 
residents from 2004-2009.
 Two kinds of questionnaires, the first for outpatient 
and the second for inpatient cases, were used for data 
collection. Items collected in GPCR consisted of the 
patient’s demographic particulars, anatomical site of the 
cancer, histology of tumor, method of diagnosis, date of 
diagnosis, method of treatment and outcome (date of death 
in case the patient has died). In some centers, data was 
collected passively ie, notifications of diagnosed cases 
were sent to the GPCR office on a routine, continuing 
basis. Thirty four health professionals underwent specific 
training for data abstraction in these centers. Data 
collection in other centers was active, the registry staff 
regularly visited them and collected information on newly 
diagnosed cancer cases. Ten percent of questionnaires 
were checked and compared with original documents in 
the source centers to verify accuracy and completeness 
of the abstraction process. 
 For classification of the lesions the third edition of 
International Classification of Diseases for Oncology 
(ICD-O-3) (Fritz et al., 2000) coding system was used; it 
applied the rules, nomenclature and codes (morphology, 
topography, and behavior) of malignant disease. IARC 
multiple primary rules (International Agency for Reseach 
on Cancer, 2004) were used for patients with malignant 
tumors in more than one site. Data was entered into 
CanReg-4 software (Parkin and Ferlay, 2001), created and 
published by the IACR. Finally, number of cases by sex, 
age and primary site as well as age standardized incidence 
rates (ASR) (per 100000 person-years) for cancers were 
calculated. 
 We needed the data of Golestan population to calculate 
incidence rates. It was obtained from the Iranian national 
census. The Iranian national census is held every 5 years 
by the Iranian statistical center. The most recent census 
was held in 2011. Regarding the period of our study 
(2004-2009), we used the data of Iranian national census 
in 2006.
 Staff of the registry were educated and asked to 
consider confidentiality in all stages of registry process 
including collection on notifications, transmission of 
information, access to and storage of data, use and release 
of data and record linkage. Confidentiality measures were 
used to ensure the preservation of anonymity of cancer 
cases, the best quality of registry data and the best possible 
usage of the data. Ethical issues of this project were 
approved by the ethical committee of Golestan University 
of Medical Sciences.
Results 
 Totally, 11036 new cancer cases were registered 
in GPRC from 2004-2009. Leukemia and multiple 
myeloma accounted for 693 and 124 of incident cases, 
respectively. The mean (SD) of age at diagnosis in patients 
with leukemia and multiple myeloma were 43.8 (24.7) 
and 62.4 (12.5) years, respectively. Table 1 shows the 
characteristics of patients with leukemia and multiple 
myeloma in Golestan province.
 The age-standard incidence rates for leukemia among 
men and women were 10.4 and 7.8 per 100,000 person- 
year, respectively (p value<0.001). The ASRs for multiple 
myeloma were 2.1 and 2 per 100000person-year in men 
and women, respectively (p value=0.93). 
 Table 2 presents number, crude rates and Age-
Standardized Rates (ASRs) of leukemia and multiple 
myeloma among men and women in Golestan province. 
Age-specific incidence rates for leukemia and multiple 
myeloma in males and females have been shown in Figure 
1. 
 The ASR of leukemia in urban and rural areas were 
8.6 and 9.7 per 100000 person-years, respectively (p 
value=0.02). The ASRs of multiple myeloma were 2.7 
Table 1. Characteristics of Patients with Leukemia 
and Multiple Myeloma in Golestan Province, Iran, 
2004-2009
Variable Leukemia Multiple Myeloma
 No.   % No.   %
Gender Male 408 58.0 63 50.8
 Female 291 42.0 61 49.2
Place of residence Urban 310 44.7 84 67.7
 Rural 383 55.3 40 32.3
Method of diagnosis Cytology 184 26.6 0 0
 Histology 509 73.4 124 100
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and 1.5 per 100000 person-years in urban and rural areas, 
respectively (p value<0.001). Male patients living in urban 
area had lower rate of leukemia than those living in rural 
areas (p value=0.19). This difference was significant 
in female patients (p value=0.04). The incidence rate 
of multiple myeloma was significantly higher in urban 
males than rural ones (p value=0.02). Similar significant 
difference was seen in female patients (p value<0.001).
 
Discussion
In this population-based study conducted in Golestan 
province, northeast of Iran, we found that the ASR of 
leukemia in men and women in Golestan province were 
10.4 and 7.8 per 100000 person-years, respectively. 
These rates were higher than those reported for Iran (7.7 
and 4.0 per 100000 person-years for men and women) 
and the world (5.8 and 4.3 per 100000 person-years for 
men and women) (Ferlay et al., 2010). Our results also 
showed higher rate of leukemia in Golestan province 
than neighboring countries including Arab world (Salim 
et al., 2009; 2010). Our findings indicated that the ASR 
of multiple myeloma among males and females were 2.1 
and 1 per 100000 person-years, respectively. The ASRs 
of multiple myeloma in Iran were 1.8 and 1 per 100000 
person-years for male and females, respectively (Ferlay 
et al., 2010). Regarding the world population, the rates 
were 1.7 and 1.2 per 100000 person-years for males, 
respectively (Ferlay et al., 2010). So, the incidence rates 
of leukemia in Golestan province of Iran were relatively 
higher than those reported for Iran as well as the world. 
Further investigations are warranted to identify risk factors 
and determinants of leukemia in this area.   
Our study showed that incidence rate of leukemia 
was significantly higher in males than females. The sex 
distribution pattern of leukemia in Golestan province 
was in line with those observed in other studies (Xie et 
al., 2003; Thygesen et al., 2009; Novak et al., 2012). It 
may be proposed that male gender is at higher risk of 
leukemia due to genetic predisposition or exposure to 
environmental factors. 
The incidence rate of leukemia was significantly 
higher in rural areas than urban areas. Because of the 
variety of risk factors involved in etiology of leukemia, 
it is difficult to identify the reasons for the high incidence 
rate of leukemia in Golestan province, particularly in rural 
areas. Recent studies reported increased risk of leukemia 
among farmers (Brown et al., 1990; Turner et al., 2011). 
Golestan province, located at southeast of Caspian Sea, 
is one of the most important poles of Iran’s farming and 
agricultural products. Consequently, high incidence of 
leukemia in rural parts of this area may be attributed to 
high exposure to potential hazardous substances including 
pesticide, grain dust, zoonotic viruses and microbes among 
those working routinely in farms (Brown et al., 1990). 
The incidence rate of multiple myeloma was 
significantly higher among people living in urban areas 
than those from rural areas. Residents of urban areas may 
expose to some carcinogenic factors especially those 
related to the development of multiple myeloma. Previous 
studies suggested that exposure to engine exhaust, asbestos 
and benzene may increase the risk of multiple myeloma 
(Baris et al., 2004). Further studies are warranted to 
investigate the environmental risk factors of multiple 
myeloma in Golestan province.
In conclusion, we found a high incidence rate of 
leukemia in Golestan province of Iran. Our results also 
showed that the incidence of leukemia was significantly 
higher in male gender and residents of rural area. 
High exposure to pesticides and other agricultural 
related products may be a possible explanation for 
epidemiological pattern of leukemia in this area. 
Determining and controlling important risk factors, 
especially environmental factors, of leukemia may lead to 
decrease its burden in Golestan province of Iran.  
 
Acknowledgements 
Authors would like to thank Mr Abbas Moghaddami, 
Mrs Honeyehsadat Mirkarimi, Miss Rose Khorasaninejhad, 
Mrs Khadijeh Amjadi and GPCR stuffs for their valuable 
collaboration. This work was supported by Golestan 
University of Medical Sciences.
References
Baris D, Silverman DT, Brown LM, et al (2004). Occupation, 
pesticide exposure and risk of multiple myeloma. Scand J 
0
25.0
50.0
75.0
100.0
N
ew
ly
 d
ia
gn
os
ed
 w
ith
ou
t 
tr
ea
tm
en
t 
N
ew
ly
 d
ia
gn
os
ed
 w
ith
 t
re
at
m
en
t 
Pe
rs
is
te
nc
e 
or
 r
ec
ur
re
nc
e
Re
m
is
si
on
N
on
e
Ch
em
ot
he
ra
py
Ra
di
ot
he
ra
py
Co
nc
ur
re
nt
 c
he
m
or
ad
ia
tio
n
10.3
0
12.8
30.025.0
20.310.16.3
51.7
75.0
51.1
30.031.3
54.2
46.856.3
27.625.0
33.130.031.3
23.7
38.0
31.3
Table 2. Number of Patients, Crude Rate* and Age 
Standardized Incidence Rate (ASR)* of Leukemia 
and Multiple Myeloma in Golestan Province, Iran, 
2004-2009
 Male Female
 No. Crude ASR No. Crude ASR
  rate   rate
Urban Multiple Myeloma 40 1.6 2.5 44 1.8 3.0
 Lymphoid Leukemia 95 3.9 5.2 42 1.8 2.5
 Myeloid Leukemia 47 1.9 2.6 32 1.3 1.9
 Leukemia unspec. 43 1.8 2.4 51 2.1 2.7
Rural Multiple Myeloma 23 0.9 1.7 17 0.7 1.1
 Lymphoid Leukemia 91 3.6 4.4 55 2.2 2.6
 Myeloid Leukemia 46 1.8 2.4 54 2.2 2.8
 Leukemia unspec. 80 3.2 4.1 57 2.3 3.0
Total Multiple Myeloma 63 1.3 2.1 61 1.3 2.0
 Lymphoid Leukemia 186 3.7 4.7 97 2.0 2.6
 Myeloid Leukemia 93 1.9 2.5 86 1.8 2.3
 Leukemia unspec. 123 2.5 3.2 108 2.2 2.9
*Per 100000 person-years
Figure 1. Age Specific Incidence Rates of Leukemia 
and Multiple Myeloma in Golestan Province of Iran, 
2004-2009
Niloofar Rajabli et al
Asian Pacific Journal of Cancer Prevention, Vol 14, 20132336
Work Environ Health, 30, 215-22.
Brown LM, Blair A, Gibson R, et al (1990). Pesticide exposures 
and other agricultural risk factors for leukemia among men 
in Iowa and Minnesota. Cancer Res, 50, 6585-91.
Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide 
burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 
127, 2893-917.
Fritz A, Percy C, Jack A, et al (2000). International Classification 
of Diseases for Oncology, Geneva: World Health Oganization.
International Agency for Reseach on Cancer, 2004. International 
rules for multiple primary cancers ICD-O-3rd ed, International 
Agency for Reseach on Cancer, Lyon.
Laubach JP, Mitsiades CS, Mahindra A, et al (2009). Novel 
therapies in the treatment of multiple myeloma. J Natl Compr 
Canc Netw, 7, 947-60.
Novak I, Jaksic O, Kulis T, Batinjan K, Znaor A (2012). 
Incidence and mortality trends of leukemia and lymphoma 
in Croatia, 1988-2009. Croat Med J, 53, 115-23.
Parkin DM, Ferlay J (2001). Canreg: computer software for 
cancer registries. 4th ed. Lyon: International Agency for 
Research on Cancer.
Rhomberg LR, Bailey LA, Goodman JE, Hamade AK, Mayfield 
D (2011). Is exposure to formaldehyde in air causally 
associated with leukemia?-A hypothesis-based weight-of-
evidence analysis. Crit Rev Toxicol, 41, 555-621.
Romanenko AY, Finch SC, Hatch M, et al (2008). The Ukrainian-
American study of leukemia and related disorders among 
chornobyl cleanup workers from Ukraine: III. Radiation 
risks. Radiat Res, 170, 711-20.
Roshandel G, Sadjadi A, Aarabi M, et al (2012). Cancer incidence 
in Golestan province: report of an ongoing population-based 
cancer registry in Iran between 2004 and 2008. Arch Iran 
Med, 15, 196-200.
Salim EI, Moore MA, Al-Lawati JA, et al (2009). Cancer 
epidemiology and control in the arab world - past, present 
and future. Asian Pac J Cancer Prev, 10, 3-16.
Salim EI, Moore MA, Bener A, et al (2010). Cancer epidemiology 
in South-West Asia - past, present and future. Asian Pac J 
Cancer Prev, 11, 33-48.
Thygesen LC, Nielsen OJ, Johansen C (2009). Trends in adult 
leukemia incidence and survival in Denmark, 1943–2003. 
Cancer Causes Control, 20, 1671-80.
Turner MC, Wigle DT, Krewski D (2011). Residential pesticides 
and childhood leukemia: a systematic review and meta-
analysis. Cien Saude Colet, 16, 1915-31.
Xie Y, Davies SM, Xiang Y, Robison LL, Ross JA (2003). Trends 
in leukemia incidence and survival in the United States 
(1973–1998). Cancer, 97, 2229-35.
Yiin JH, Anderson JL, Daniels RD, et al (2009). A nested 
case-control study of multiple myeloma risk and uranium 
exposure among workers at the Oak Ridge Gaseous 
Diffusion Plant. Radiat Res, 176, 637-645.
